Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer
- 1 November 2006
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 42 (17) , 3057-3064
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice GuidelineJournal of Clinical Oncology, 2005
- Mechanisms of Disease: defensins in gastrointestinal diseasesNature Clinical Practice Gastroenterology & Hepatology, 2005
- Discovery and Identification of α-Defensins as Low Abundant, Tumor-Derived Serum Markers in Colorectal CancerGastroenterology, 2005
- Identification of Defensin α6 as a Potential Biomarker in Colon AdenocarcinomaJournal of Biological Chemistry, 2005
- Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker studyBMC Cancer, 2005
- α-Defensins in the gastrointestinal tractMolecular Immunology, 2003
- Defensins: antimicrobial peptides of innate immunityNature Reviews Immunology, 2003
- Clinical utility of biochemical markers in colorectal cancerEuropean Journal of Cancer, 2003
- Colorectal Cancer ScreeningJAMA, 2003
- The case for population-based screening for colorectal cancerNature Reviews Cancer, 2002